An interventional study of Sphenopalatine Ganglion Block and Sham Block in Bimaxillar Surgery and Sphenopalatine Ganglion Block, sponsored by Bezmialem Vakif University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-04-18.
Sponsored by Bezmialem Vakif University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Pain by Bezmialem Vakif University — 3 open to participants now, 3 under way, none of them phase 3. Pain · Bezmialem Vakif University.
Among the 10 studies in Pain by Bezmialem Vakif University, this one is the only one that started in 2024, is one of 9 with no phase, and was the 6th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →3 of the 10 studies in Pain by Bezmialem Vakif University are open now, in 1 country. Recruiting first, the newest first:
Bezmialem Vakif University · Sites in Turkey
Ages 18–65 · Healthy volunteers
Bezmialem Vakif University · Sites in Turkey
Ages 16–55 · Healthy volunteers
By country, each count listing its studies:
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years to 45 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 1 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 60 across the 9 interventional studies, 49 across the 1 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Bezmialem Vakif University is the lead sponsor of 359 studies on the registry; 61 are open to participants now.
1 of the studies in Pain by Bezmialem Vakif University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07062757Bezmialem Vakif UniversityLymphatic Drainage Massage and Melatonin in Post-Orthognathic Surgery Pain and Edema | 2027-03-30 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Pain by Bezmialem Vakif University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to evaluate whether sphenopalatine ganglion (SPG) block helps with intraoperative pain control, reduces postoperative edema, and decreases pain in adults aged 18 to 45 undergoing bimaxillary orthognathic surgery.
The main questions it aims to answer are:
Participants will:
Orthognathic surgery is a procedure used to correct jaw bone problems that are present from birth or develop over time. During this surgery, multiple cuts, tissue separation, and bone reshaping (osteotomy) are done on the upper and lower jaw. After the surgery, the body responds with an inflammatory reaction, causing edema and pain. As the tissues heal, the edema and pain gradually decrease.
Edema is a common result of orthognathic surgery and can affect recovery time, return to normal activities, and hospital stay. Research shows that reducing edema can improve a patient's quality of life. Excessive edema can also cause pain and discomfort. To manage this, treatments such as steroids, laser therapy, lymphatic drainage massage, and cold applications are used.
The SPG is a nerve center that contains both sensory and autonomic nerve fibers. It connects to the trigeminal nerve, facial nerve, internal carotid plexus, and superior cervical ganglion. The SPG plays a role in widening brain blood vessels, providing sensation to the soft palate, tonsils, upper lip, and mouth floor, and controlling tear gland secretions.
In our study, it is anticipated that SPG block may help prevent intraoperative abnormal hemodynamic changes (by facilitating the control of heart rate and mean arterial pressure), reduce bleeding, decrease anesthetic drug consumption, lower the incidence of postoperative nausea and vomiting, and improve postoperative pain control and edema reduction. As a result, the postoperative comfort of patients undergoing orthognathic surgery can be enhanced with a cost-effective and easily applicable method, potentially reducing the risk of chronic pain in the long term. Additionally, by minimizing surgery-related edema and jaw muscle spasms, patients may achieve an optimal quality of life more quickly. Due to the limited number of studies on this technique in oral and maxillofacial surgery, our study is expected to pave the way for future research in this area.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This group will receive a SPG block using 4 ml of 5% bupivacaine after entübastion.
Procedure: Sphenopalatine Ganglion Block
This group will receive a sham block using the same method using 4 ml of physiological saline after intubation.
Procedure: Sham Block
To perform an SPG block, the ultrasound linear probe is placed parallel to the zygomatic bone, facing anteriorly, to obtain an image that includes the ramus of the maxilla and mandible and the pterygoid process of the sphenoid bone. A 23-gauge, 50 mm needle is inserted just behind the posterior orbital rim and advanced in an antero-caudal direction over the zygomatic arch. When the needle reaches the pterygopalatine fossa at approximately 5 cm, aspiration is performed to check for blood. If no blood is seen, 4 mL of 0.5% bupivacaine is injected. The procedure is performed on both sides
Also known as: Meckel ganglion block, pterygopalatine ganglion block
To perform a Sham block, the ultrasound linear probe is placed parallel to the zygomatic bone, facing anteriorly, to obtain an image that includes the ramus of the maxilla and mandible and the pterygoid process of the sphenoid bone. A 23-gauge, 50 mm needle is inserted just behind the posterior orbital rim and advanced in an antero-caudal direction over the zygomatic arch. When the needle reaches the pterygopalatine fossa at approximately 5 cm, aspiration is performed to check for blood. If no blood is seen, 4 mL of %0,9 NaCl is injected. The procedure is performed on both sides.
Postoperative Edema
Using the technique of Gabka and Matsumura, gonion, mentum, and tragus are marked with methylene blue before surgery. The distances between the marks are measured bilaterally in millimeters using a flexible ruler and recorded. The measurement points will include: * Tragus-labial commissure distance * Tragus-alar notch distance * Gonion-lateral canthus distance * Tragus-mentum distance Postoperatively, edema measurements are taken from the same points.
Time frame: Measurements are taken preoperatively, at 24 hours postoperatively, on postoperative day 3, day 7 and at 1 month.
Postoperative Pain
The numeric rating scale(NRS) is used to evaluate postoperative pain. Patients are asked to rate their pain on the scale of 0 to 10, with 0 indicating no pain and 10 indicating unbearable pain. Nrs scores are recorded.
Time frame: The patient's pain at rest and during movement is evaluated at 30 minutes, 6 hours, 12 hours, 24 hours and 48 hours following the end of the surgery.
Effect of the Block on Temperature
Starting before the block, the forehead skin temperature will be recorded every 5 minutes for 1 hour. During this period, the block time and surgical draping time are noted.
Time frame: Measurements are taken every 5 minutes for the first 1 hour after induction.
Heart rate
Heart rate is monitored and recorded perioperatively using noninvasive monitoring.
Time frame: Measurements are taken every 15 minutes preoperatively and throughout the surgery
Mean arterial pressure
Mean arterial pressure is monitored and recorded perioperatively using noninvasive monitoring.
Time frame: Measurements are taken every 15 minutes preoperatively and throughout the surgery
Opioid and Anesthetic Agent Consumption
The amount of sevoflurane required to maintain the bispectral index (BIS) value within the target range and the total remifentanil used are recorded at the end of each patient's surgery.
Time frame: The agents used during surgery are recorded once at the end of anesthesia.
Quality of the surgical field
The surgeon assesses the quality of the surgical field using a predefined category scale, adapted from Fromme GA et al. at the end of the surgery. Fromme Scale : * Grade 1: Massive uncontrollable bleeding * Grade 2: Bleeding, heavy but controllable, that significantly interferes with dissection * Grade 3: Moderate bleeding that moderately compromises surgical dissection * Grade 4: Moderate bleeding, a nuisance but without interfering with aaccurate dissection * Grade 5: Bleeding, so mild it was not even a surgical nuisance * Grade 6: No bleeding, virtually bloodless field
Time frame: That is recorded once at the end of surgery.
Postoperative Analgesic Consumption
As a secondary parameter for pain assessment, the amount of opioid analgesic (tramadol) used, the number of requests and the need for rescue analgesics are recorded through patient-controlled analgesia devices.
Time frame: These assessments are recorded at 30 minutes, 6 hours, postoperative day 1, day 2 and day 3.
Mouth Opening
The distance between font teeth is measured and recorded with soft ruler.
Time frame: Measurements are taken preoperatively, on postoperative day 1, day 3, and day 7.
Nausea and Vomiting
Nausea and vomiting are evaluated using a 4-point categorical scale 0 = No nausea 1. = Nausea only 2. = Nausea with retching 3. = Vomiting
Time frame: These assessments are recorded at 30 minutes, 6 hours, postoperative day 1, day 2 and day 3.
Plan to share: No
Started Jun 2024 (actual). Primary completion is estimated for May 2025, 10 months after the start.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 10 months is close to that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.